
DISCOVER WHAT WORKS FASTER




Rx A

No Response
Rx B

Rx A

Rx B

Response
Enhanced Response
Accelerating Immuno-Oncology candidates to and through clinic
Drug Impact
Our proprietary technology ensures preservation of human TiME,
to ascertain immunomodulatory strategies
Our customizable assay system provides a flexible and comprehensive approach to prioritization of combinatorial strategies
Our platform's integrated phenotypic outcome and multi-omic data are useful in understanding the potential mechanisms of action that underlie a response of interest
A variety of comprehensive readouts allow for identification of biomarkers that could potentially differentiate likely response to drug candidates and optimize patient stratification for clinical trials